Showing results (571-580 of 597) with videos related to
Sort By:
Pageof 60
Cancer|November 7, 2023
Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5Daniel J Benedetti, Carly R Varela, Lindsay A Renfro, et al.The Lancet. Oncology|September 1, 2019
Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor StudyAndrew C Dietz, Kristy Seidel, Wendy M Leisenring, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2017
Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine ColitisLuigi Franchi, Ivan Monteleone, Ling-Yang Hao, et al.The Journal of Surgical Research|January 8, 2025
Impact of Locum Tenens Providers on Delivery of Pediatric Surgical CareLindsey L Wolf, David E Skarda, Jason C Fisher, et al.Pediatrics|February 18, 2025
Factors Associated With Delay to Care in Pediatric and Adolescent Adnexal TorsionBarrie S Rich, Bailey Roberts, Colleen Nofi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2025
Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN0533David B Dix, Geetika Khanna, Lindsay A Renfro, et al.Journal of the American College of Surgeons|January 22, 2024
Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2Harold N Lovvorn, Lindsay A Renfro, Daniel J Benedetti, et al.Oncoimmunology|January 27, 2017
Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunityXiao Hu, Xikui Liu, Jacques Moisan, et al.Annals of Surgery|March 27, 2020
Pneumonectomy for Pediatric Tumors-a Pediatric Surgical Oncology Research Collaborative StudyStephanie F Polites, Todd E Heaton, Michael P LaQuaglia, et al.Journal of Medicinal Chemistry|March 4, 2025
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome InhibitorDong-Ming Shen, Kate F Byth, Damien Bertheloot, et al.Pageof 60